Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 7.332 Q1 | 391 | 162 | 916 | 7271 | 5779 | 265 | 5.58 | 44.88 |  |
| 2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 6.223 Q1 | 70 | 8 | 44 | 1340 | 537 | 44 | 8.71 | 167.50 |  |
| 3 | Trends in Pharmacological Sciences | journal | 4.402 Q1 | 244 | 104 | 356 | 5460 | 3669 | 324 | 10.55 | 52.50 | |
| 4 | Cellular and Molecular Life Sciences | journal | 2.857 Q1 | 261 | 258 | 782 | 24555 | 4185 | 776 | 5.10 | 95.17 |  |
| 5 | Current Opinion in Pharmacology | journal | 2.803 Q1 | 148 | 98 | 308 | 4299 | 2098 | 279 | 7.45 | 43.87 |  |
| 6 | Advanced Drug Delivery Reviews | journal | 2.778 Q1 | 366 | 107 | 365 | 10459 | 3360 | 303 | 8.61 | 97.75 | |
| 7 | Natural Product Reports | journal | 2.753 Q1 | 211 | 53 | 128 | 9245 | 950 | 123 | 7.73 | 174.43 | |
| 8 | Neuropsychopharmacology | journal | 2.724 Q1 | 249 | 285 | 762 | 16343 | 4804 | 734 | 6.33 | 57.34 | |
| 9 | Journal of Molecular Medicine | journal | 2.697 Q1 | 157 | 116 | 311 | 5708 | 1685 | 293 | 5.31 | 49.21 | |
| 10 | Human Genomics | journal | 2.394 Q1 | 68 | 33 | 65 | 1350 | 246 | 61 | 3.83 | 40.91 | |
| 11 | Neurotherapeutics | journal | 1.932 Q1 | 136 | 53 | 109 | 4821 | 655 | 98 | 6.01 | 90.96 | |
| 12 | Neuropharmacology | journal | 1.921 Q1 | 191 | 229 | 730 | 10800 | 3166 | 727 | 4.37 | 47.16 | |
| 13 | Psychopharmacology | journal | 1.892 Q1 | 214 | 366 | 1156 | 19456 | 5043 | 1107 | 4.18 | 53.16 | |
| 14 | Drug and Alcohol Dependence | journal | 1.854 Q1 | 187 | 210 | 463 | 8779 | 1946 | 452 | 3.93 | 41.80 |  |
| 15 | Current Drug Metabolism | journal | 1.835 Q1 | 122 | 65 | 123 | 7593 | 861 | 117 | 6.92 | 116.82 | |
| 16 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 1.826 Q1 | 35 | 0 | 14 | 0 | 57 | 14 | 0.00 | 0.00 | |
| 17 | Antiviral Therapy | journal | 1.790 Q1 | 93 | 126 | 326 | 4438 | 1413 | 312 | 4.46 | 35.22 | |
| 18 | Journal of Controlled Release | journal | 1.788 Q1 | 313 | 340 | 996 | 11303 | 4961 | 992 | 4.47 | 33.24 | |
| 19 | International Journal of Neuropsychopharmacology | journal | 1.777 Q1 | 125 | 95 | 201 | 3483 | 855 | 169 | 4.22 | 36.66 | |
| 20 | Journal of Antimicrobial Chemotherapy | journal | 1.771 Q1 | 221 | 485 | 1381 | 11635 | 5642 | 1169 | 4.07 | 23.99 | |
| 21 | Apoptosis : an international journal on programmed cell death | journal | 1.761 Q1 | 128 | 192 | 283 | 9438 | 1189 | 281 | 3.73 | 49.16 | |
| 22 | Environmental Pollution | journal | 1.679 Q1 | 301 | 433 | 889 | 16737 | 2998 | 881 | 3.09 | 38.65 | |
| 23 | Controlled Clinical Trials | journal | 1.648 Q1 | 76 | 0 | 117 | 0 | 406 | 106 | 4.30 | 0.00 | |
| 24 | Critical Reviews in Toxicology | journal | 1.537 Q1 | 129 | 29 | 69 | 4381 | 317 | 63 | 3.80 | 151.07 | |
| 25 | Clinical Pharmacokinetics | journal | 1.534 Q1 | 184 | 82 | 241 | 5255 | 1530 | 238 | 5.41 | 64.09 | |
| 26 | Tetrahedron | journal | 1.524 Q1 | 236 | 1309 | 3497 | 60611 | 10440 | 3480 | 2.95 | 46.30 | |
| 27 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.511 Q1 | 106 | 55 | 176 | 1629 | 527 | 174 | 2.77 | 29.62 | |
| 28 | Particle and Fibre Toxicology | journal | 1.458 Q1 | 119 | 16 | 14 | 852 | 74 | 13 | 5.29 | 53.25 | |
| 29 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.446 Q1 | 99 | 24 | 48 | 3594 | 210 | 45 | 4.00 | 149.75 | |
| 30 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | |
| 31 | European Neuropsychopharmacology | journal | 1.382 Q1 | 130 | 91 | 258 | 4338 | 995 | 256 | 4.03 | 47.67 | |
| 32 | Pharmacogenomics Journal | journal | 1.357 Q1 | 95 | 54 | 158 | 2304 | 673 | 139 | 4.74 | 42.67 | |
| 33 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | |
| 34 | British Journal of Clinical Pharmacology, Supplement | journal | 1.331 Q1 | 33 | 0 | 18 | 0 | 60 | 17 | 1.00 | 0.00 | |
| 35 | Toxicological Sciences | journal | 1.327 Q1 | 207 | 333 | 894 | 14700 | 3449 | 860 | 3.83 | 44.14 | |
| 36 | Tetrahedron Letters | journal | 1.314 Q1 | 181 | 1965 | 6158 | 57964 | 16635 | 6157 | 2.65 | 29.50 | |
| 37 | European Journal of Pharmaceutics and Biopharmaceutics | journal | 1.313 Q1 | 185 | 131 | 384 | 3603 | 1353 | 377 | 3.84 | 27.50 | |
| 38 | American Journal of Respiratory Medicine | journal | 1.279 Q1 | 34 | 0 | 42 | 0 | 173 | 42 | 0.00 | 0.00 | |
| 39 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | |
| 40 | Drug Discovery Today | journal | 1.251 Q1 | 215 | 161 | 1060 | 7603 | 3278 | 847 | 3.22 | 47.22 | |
| 41 | Current Drug Targets: Inflammation and Allergy | journal | 1.209 Q1 | 53 | 0 | 172 | 0 | 620 | 159 | 3.62 | 0.00 | |
| 42 | Journal of Psychopharmacology | journal | 1.183 Q1 | 135 | 144 | 275 | 6477 | 851 | 238 | 3.09 | 44.98 | |
| 43 | Receptors and Channels | journal | 1.143 Q1 | 44 | 0 | 59 | 0 | 169 | 56 | 2.53 | 0.00 | |
| 44 | Antiviral Research | journal | 1.139 Q1 | 151 | 118 | 262 | 5565 | 980 | 260 | 3.40 | 47.16 | |
| 45 | Journal of Nanobiotechnology | journal | 1.124 Q1 | 109 | 14 | 27 | 465 | 106 | 27 | 4.33 | 33.21 | |
| 46 | Current Opinion in Investigational Drugs | journal | 1.120 Q1 | 83 | 132 | 484 | 7673 | 1527 | 446 | 3.01 | 58.13 | |
| 47 | Addictive Behaviors | journal | 1.118 Q1 | 149 | 228 | 512 | 6951 | 1315 | 510 | 2.42 | 30.49 | |
| 48 | Toxicon | journal | 1.115 Q1 | 144 | 217 | 706 | 8412 | 1821 | 694 | 2.64 | 38.76 | |
| 49 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | |
| 50 | Investigational New Drugs | journal | 1.068 Q1 | 97 | 64 | 165 | 2161 | 577 | 162 | 3.27 | 33.77 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data